BR0005318A - Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade - Google Patents

Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade

Info

Publication number
BR0005318A
BR0005318A BR0005318-0A BR0005318A BR0005318A BR 0005318 A BR0005318 A BR 0005318A BR 0005318 A BR0005318 A BR 0005318A BR 0005318 A BR0005318 A BR 0005318A
Authority
BR
Brazil
Prior art keywords
apo
obesity
mtp
obesity agents
secretion inhibitors
Prior art date
Application number
BR0005318-0A
Other languages
English (en)
Inventor
Bradley Paul Morgan
Andrew Gordon Swick
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0005318A publication Critical patent/BR0005318A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B>"UTILIZAçãO DE INIBIDORES DE SECREçãO DA apo B/MTP E AGENTES ANTIOBESIDADE"<D>. A invenção fonece métodos e composições farmacêuticaas úteis no tratamento da obesidade num animal, preferencialmente um mamífero incluindo um paciente humano, um animal de companhia, ou gado, utilizando um inibidor de secreção apo B/MTP e um agente antiobesidade. A invenção também está relacionada com um kit compreendendo uma quantidade de um inibidor de secreção de apolipoproteína B/proteína de transferência de triglicerídeo microssomal e um carreador, veículo ou diluente farmaceuticamente aceitável na forma de uma primeira dose unitária; uma quantidade de um agente antiobesidade e um carreador, veículo ou diluente farmaceuticamente aceitável na forma de uma segunda dose unitária; e um recipiente.
BR0005318-0A 1999-11-10 2000-11-09 Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade BR0005318A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478099P 1999-11-10 1999-11-10

Publications (1)

Publication Number Publication Date
BR0005318A true BR0005318A (pt) 2001-08-07

Family

ID=22596056

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0005318-0A BR0005318A (pt) 1999-11-10 2000-11-09 Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade

Country Status (4)

Country Link
EP (1) EP1099441A3 (pt)
JP (1) JP2001139491A (pt)
BR (1) BR0005318A (pt)
CA (1) CA2324801A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
EP1463751B1 (en) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albumin fusion proteins
US6825209B2 (en) 2002-04-15 2004-11-30 Research Triangle Institute Compounds having unique CB1 receptor binding selectivity and methods for their production and use
EP1457206A1 (en) * 2003-03-13 2004-09-15 Fournier Laboratories Ireland Limited Combined use of a fibrate and orlistat for the treatment of obesity
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474993A (en) * 1994-06-14 1995-12-12 Sterling Winthrop, Inc. Lactam inhibitors of cholesterol esterase
EP0832069B1 (en) * 1995-06-07 2003-03-05 Pfizer Inc. BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
ATE223400T1 (de) * 1996-04-30 2002-09-15 Pfizer Verfahren und zwischenprodukte zur herstellung von 4-trifluoromethylbiphenyl-2-carbonsaüre,(2- (2h-(1,2,4) triazol-3-ylmethyl)-1,2,3,4- tetrahydro-isoquinolin-6-yl)-amide
KR100334567B1 (ko) * 1996-11-27 2002-05-03 디. 제이. 우드, 스피겔 알렌 제이 아포 비-분비/엠티피 억제성 아미드
US5968950A (en) * 1997-06-23 1999-10-19 Pfizer Inc Apo B-secretion/MTP inhibitor hydrochloride salt
IL133201A0 (en) * 1998-12-04 2001-03-19 Pfizer Prod Inc Lowering blood levels of lipoproten (a)

Also Published As

Publication number Publication date
EP1099441A3 (en) 2002-12-04
CA2324801A1 (en) 2001-05-10
EP1099441A2 (en) 2001-05-16
JP2001139491A (ja) 2001-05-22

Similar Documents

Publication Publication Date Title
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EP1769791A3 (en) Treatment of Alzheimer&#39;s disease with cell cycle inhibitors
HUP0301194A3 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
IL151371A (en) Modified porcine factor viii and pharmaceutical compositions containing the same
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l&#39;usage pour la prevention ou le traitement de la hyper-oxalurie
ATE175114T1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten
HK1076379A1 (en) Use of a composition comprising anti-vla-1 antibody for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis
BR9906920A (pt) &#34;tts contendo um antioxidante&#34;
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
EP1178988A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
DE59409735D1 (de) ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN
TR200101633T2 (tr) Farmasötik bileşim
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BR0005318A (pt) Utilização de inibidores de secreção da apo b/mtp e agentes antiobesidade
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
EP1099439A3 (en) Use of apo B secretion/MTP inhibitors
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
CA2325282A1 (en) Use of apo b secretion/mtp inhibitors
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired